메뉴 건너뛰기




Volumn 80, Issue 9, 2005, Pages 1170-1176

Evaluation of the optimal oral antihistamine for patients with allergic rhinitis

Author keywords

[No Author keywords available]

Indexed keywords

ANTIHISTAMINIC AGENT; ASTEMIZOLE; BROMPHENIRAMINE; CETIRIZINE; CHLORPHENIRAMINE; CLEMASTINE; DESLORATADINE; DIPHENHYDRAMINE; EBASTINE; ERYTHROMYCIN; FEXOFENADINE; HYDROXYZINE; KETOCONAZOLE; LEVOCETIRIZINE; LORATADINE; TERFENADINE;

EID: 24144473621     PISSN: 00256196     EISSN: None     Source Type: Journal    
DOI: 10.4065/80.9.1170     Document Type: Review
Times cited : (24)

References (88)
  • 1
    • 0026334918 scopus 로고
    • Epidemiology of seasonal and perennial rhinitis: Clinical presentation and medical history
    • Sibbald B, Rink E. Epidemiology of seasonal and perennial rhinitis: clinical presentation and medical history. Thorax. 1991;46:895-901.
    • (1991) Thorax , vol.46 , pp. 895-901
    • Sibbald, B.1    Rink, E.2
  • 2
    • 0031158329 scopus 로고    scopus 로고
    • The prevalence and medical and economic impact of allergic rhinitis in the United States
    • Meltzer EO. The prevalence and medical and economic impact of allergic rhinitis in the United States. J Allergy Clin Immunol. 1997;99(6, pt 2):S805-S828.
    • (1997) J Allergy Clin Immunol , vol.99 , Issue.6 PART 2
    • Meltzer, E.O.1
  • 4
    • 0029785409 scopus 로고    scopus 로고
    • Allergic rhinitis: Clinical practice guideline
    • Fornadley JA, Corey JP, Osguthorpe JD, et al, Committee on Practice Standards, American Academy of Otolaryngic Allergy. Allergic rhinitis: clinical practice guideline. Otolaryngol Head Neck Surg. 1996;115:115-122.
    • (1996) Otolaryngol Head Neck Surg , vol.115 , pp. 115-122
    • Fornadley, J.A.1    Corey, J.P.2    Osguthorpe, J.D.3
  • 5
    • 0035198737 scopus 로고    scopus 로고
    • Allergic rhinitis and its impact on asthma
    • Bousquet J, van Cauwenberge P, Khaltaev N, ARIA Workshop Group, World Health Organization. Allergic rhinitis and its impact on asthma. J Allergy Clin Immunol. 2001;108(5, suppl):S147-S334.
    • (2001) J Allergy Clin Immunol , vol.108 , Issue.5 SUPPL.
    • Bousquet, J.1    Van Cauwenberge, P.2    Khaltaev, N.3
  • 6
    • 0028111223 scopus 로고
    • Assessment of quality of life in patients with perennial allergic rhinitis with the French version of the SF-36 Health Status Questionnaire
    • Bousquet J, Bullinger M, Fayol C, Marquis P, Valentin B, Burtin B. Assessment of quality of life in patients with perennial allergic rhinitis with the French version of the SF-36 Health Status Questionnaire. J Allergy Clin Immunol. 1994;94(2, pt 1):182-188.
    • (1994) J Allergy Clin Immunol , vol.94 , Issue.2 PART 1 , pp. 182-188
    • Bousquet, J.1    Bullinger, M.2    Fayol, C.3    Marquis, P.4    Valentin, B.5    Burtin, B.6
  • 9
    • 0033963977 scopus 로고    scopus 로고
    • Consensus statement on the treatment of allergic rhinitis
    • van Cauwenberge P, Bachert C, Passalacqua G, et al, European Academy of Allergology and Clinical Immunology. Consensus statement on the treatment of allergic rhinitis. Allergy. 2000;55:116-134.
    • (2000) Allergy , vol.55 , pp. 116-134
    • Van Cauwenberge, P.1    Bachert, C.2    Passalacqua, G.3
  • 10
    • 0037728834 scopus 로고    scopus 로고
    • First do no harm: Managing antihistamine impairment in patients with allergic rhinitis
    • Casale TB, Blaiss MS, Gelfand E, et al, Antihistamine Impairment Roundtable. First do no harm: managing antihistamine impairment in patients with allergic rhinitis. J Allergy Clin Immunol. 2003;111:S835-S842.
    • (2003) J Allergy Clin Immunol , vol.111
    • Casale, T.B.1    Blaiss, M.S.2    Gelfand, E.3
  • 11
    • 0035843316 scopus 로고    scopus 로고
    • Allergy and allergic diseases
    • Kay AB. Allergy and allergic diseases. N Engl J Med. 2001;344:30-37.
    • (2001) N Engl J Med , vol.344 , pp. 30-37
    • Kay, A.B.1
  • 12
    • 0021831728 scopus 로고
    • Inflammatory mediators in late antigen-induced rhinitis
    • Naclerio RM, Proud D, Togias AG, et al. Inflammatory mediators in late antigen-induced rhinitis. N Engl J Med. 1985;313:65-70.
    • (1985) N Engl J Med , vol.313 , pp. 65-70
    • Naclerio, R.M.1    Proud, D.2    Togias, A.G.3
  • 14
    • 0028070733 scopus 로고
    • Histamine induces interleukin-8 secretion by endothelial cells
    • Jeannin P, Delneste Y, Gosset P, et al. Histamine induces interleukin-8 secretion by endothelial cells. Blood. 1994;84:2229-2233.
    • (1994) Blood , vol.84 , pp. 2229-2233
    • Jeannin, P.1    Delneste, Y.2    Gosset, P.3
  • 15
    • 0030218814 scopus 로고    scopus 로고
    • Histamine enhanced the TNF-alpha-induced expression of E-selectin and ICAM-1 on vascular endothelial cells
    • Miki I, Kusano A, Ohta S, et al. Histamine enhanced the TNF-alpha-induced expression of E-selectin and ICAM-1 on vascular endothelial cells. Cell Immunol. 1996;171:285-288.
    • (1996) Cell Immunol , vol.171 , pp. 285-288
    • Miki, I.1    Kusano, A.2    Ohta, S.3
  • 16
    • 0028348206 scopus 로고
    • Histamine induces leukocyte rolling in post-capillary venules: A P-selectin-mediated event
    • Kubes P, Kanwar S. Histamine induces leukocyte rolling in post-capillary venules: a P-selectin-mediated event. J Immunol. 1994;152:3570-3577.
    • (1994) J Immunol , vol.152 , pp. 3570-3577
    • Kubes, P.1    Kanwar, S.2
  • 17
    • 0028215642 scopus 로고
    • Role of H1 receptors and P-selectin in histamine-induced leukocyte rolling and adhesion in postcapillary venules
    • Asako H, Kurose I, Wolf R, et al. Role of H1 receptors and P-selectin in histamine-induced leukocyte rolling and adhesion in postcapillary venules. J Clin Invest. 1994;93:1508-1515.
    • (1994) J Clin Invest , vol.93 , pp. 1508-1515
    • Asako, H.1    Kurose, I.2    Wolf, R.3
  • 18
    • 0002956172 scopus 로고
    • International Consensus Report on the diagnosis and management of rhinitis
    • International Rhinitis Management Working Group. International Consensus Report on the diagnosis and management of rhinitis. Allergy. 1994;49(19,suppl):1-34
    • (1994) Allergy , vol.49 , Issue.19 SUPPL. , pp. 1-34
  • 19
    • 0031789449 scopus 로고    scopus 로고
    • Diagnosis and management of rhinitis: Complete guidelines of the Joint Task Force on Practice Parameters in Allergy, Asthma and Immunology
    • Dykewicz MS, Fineman S, Skoner DP, et al, American Academy of Allergy, Asthma, and Immunology. Diagnosis and management of rhinitis: complete guidelines of the Joint Task Force on Practice Parameters in Allergy, Asthma and Immunology. Ann Allergy Asthma Immunol. 1998;81(5, pt 2):478-518.
    • (1998) Ann Allergy Asthma Immunol , vol.81 , Issue.5 PART 2 , pp. 478-518
    • Dykewicz, M.S.1    Fineman, S.2    Skoner, D.P.3
  • 21
    • 0036417223 scopus 로고    scopus 로고
    • 1-antihistamine for the 21st century
    • 1-antihistamine for the 21st century. Clin Exp Allergy Rev. 2002;2:18-25.
    • (2002) Clin Exp Allergy Rev , vol.2 , pp. 18-25
    • Howarth, P.H.1
  • 22
    • 0032711088 scopus 로고    scopus 로고
    • Double-blind, placebo-controlled study comparing the efficacy and safety of fexofenadine hydrochloride (120 and 180 mg once daily) and cetirizine in seasonal allergic rhinitis
    • Howarth PH, Stern MA, Roi L, Reynolds R, Bousquet J. Double-blind, placebo-controlled study comparing the efficacy and safety of fexofenadine hydrochloride (120 and 180 mg once daily) and cetirizine in seasonal allergic rhinitis. J Allergy Clin Immunol. 1999;104:927-933.
    • (1999) J Allergy Clin Immunol , vol.104 , pp. 927-933
    • Howarth, P.H.1    Stern, M.A.2    Roi, L.3    Reynolds, R.4    Bousquet, J.5
  • 23
    • 0029881492 scopus 로고    scopus 로고
    • Comparative study of cetirizine and terfenadine versus placebo in the symptomatic management of seasonal allergic rhinitis
    • Lockey RF, Widlitz MD, Mitchell DQ, et al. Comparative study of cetirizine and terfenadine versus placebo in the symptomatic management of seasonal allergic rhinitis. Ann Allergy Asthma Immunol. 1996;76:448-454.
    • (1996) Ann Allergy Asthma Immunol , vol.76 , pp. 448-454
    • Lockey, R.F.1    Widlitz, M.D.2    Mitchell, D.Q.3
  • 24
    • 0025892691 scopus 로고
    • Double-blind comparison of cetirizine and placebo in the treatment of seasonal rhinitis
    • Falliers CJ, Brandon ML, Buchman E, et al. Double-blind comparison of cetirizine and placebo in the treatment of seasonal rhinitis. Ann Allergy. 1991;66:257-262.
    • (1991) Ann Allergy , vol.66 , pp. 257-262
    • Falliers, C.J.1    Brandon, M.L.2    Buchman, E.3
  • 25
    • 34248352628 scopus 로고    scopus 로고
    • 24-Hour efficacy of once-daily desloratadine therapy in patients with seasonal allergic rhinitis [ISRCTN32042139]
    • Salmun LM, Lorber R. 24-hour efficacy of once-daily desloratadine therapy in patients with seasonal allergic rhinitis [ISRCTN32042139]. BMC Fam Pract. 2002;3:14.
    • (2002) BMC Fam Pract , vol.3 , pp. 14
    • Salmun, L.M.1    Lorber, R.2
  • 26
    • 0036408830 scopus 로고    scopus 로고
    • Effects of fexofenadine and desloratadine on subjective and objective measures of nasal congestion in seasonal allergic rhinitis
    • Wilson AM, Haggart K, Sims EJ, Lipworth BJ. Effects of fexofenadine and desloratadine on subjective and objective measures of nasal congestion in seasonal allergic rhinitis. Clin Exp Allergy. 2002;32:1504-1509.
    • (2002) Clin Exp Allergy , vol.32 , pp. 1504-1509
    • Wilson, A.M.1    Haggart, K.2    Sims, E.J.3    Lipworth, B.J.4
  • 27
    • 0037338987 scopus 로고    scopus 로고
    • Efficacy and safety of desloratadine in the treatment of perennial allergic rhinitis
    • Simons FE, Prenner BM, Finn A Jr, Desloratadine Study Group. Efficacy and safety of desloratadine in the treatment of perennial allergic rhinitis. J Allergy Clin Immunol. 2003;111:617-622.
    • (2003) J Allergy Clin Immunol , vol.111 , pp. 617-622
    • Simons, F.E.1    Prenner, B.M.2    Finn Jr., A.3
  • 29
    • 0033127413 scopus 로고    scopus 로고
    • Safety and efficacy of once-daily fexofenadine HCl in the treatment of autumn seasonal allergic rhinitis
    • Casale TB, Andrade C, Qu R. Safety and efficacy of once-daily fexofenadine HCl in the treatment of autumn seasonal allergic rhinitis. Allergy Asthma Proc. 1999;20:193-198.
    • (1999) Allergy Asthma Proc , vol.20 , pp. 193-198
    • Casale, T.B.1    Andrade, C.2    Qu, R.3
  • 30
    • 0034041361 scopus 로고    scopus 로고
    • Comparison of the efficacy, safety and quality of life provided by fexofenadine hydrochloride 120 mg, loratadine 10 mg and placebo administered once daily for the treatment of seasonal allergic rhinitis
    • van Cauwenberge P, Juniper EF. Comparison of the efficacy, safety and quality of life provided by fexofenadine hydrochloride 120 mg, loratadine 10 mg and placebo administered once daily for the treatment of seasonal allergic rhinitis. Clin Exp Allergy. 2000;30:891-899.
    • (2000) Clin Exp Allergy , vol.30 , pp. 891-899
    • Van Cauwenberge, P.1    Juniper, E.F.2
  • 31
    • 0023212250 scopus 로고
    • Safety and efficacy of loratadine (Sch-29851): A new non-sedating antihistamine in seasonal allergic rhinitis
    • Dockhorn RJ, Bergner A, Connell JT, et al. Safety and efficacy of loratadine (Sch-29851): a new non-sedating antihistamine in seasonal allergic rhinitis. Ann Allergy. 1987;58:407-411.
    • (1987) Ann Allergy , vol.58 , pp. 407-411
    • Dockhorn, R.J.1    Bergner, A.2    Connell, J.T.3
  • 32
    • 0023881399 scopus 로고
    • Double-blind placebo-controlled study of loratadine, mequitazine, and placebo in the symptomatic treatment of seasonal allergic rhinitis
    • Skassa-Brociek W, Bousquet J, Montes F, et al. Double-blind placebo-controlled study of loratadine, mequitazine, and placebo in the symptomatic treatment of seasonal allergic rhinitis. J Allergy Clin Immunol. 1988;81:725-730.
    • (1988) J Allergy Clin Immunol , vol.81 , pp. 725-730
    • Skassa-Brociek, W.1    Bousquet, J.2    Montes, F.3
  • 33
    • 0031971826 scopus 로고    scopus 로고
    • Cetirizine, loratadine, or placebo in subjects with seasonal allergic rhinitis: Effects after controlled ragweed pollen challenge in an environmental exposure unit
    • Day JH, Briscoe M, Widlitz MD. Cetirizine, loratadine, or placebo in subjects with seasonal allergic rhinitis: effects after controlled ragweed pollen challenge in an environmental exposure unit. J Allergy Clin Immunol. 1998;101:638-645.
    • (1998) J Allergy Clin Immunol , vol.101 , pp. 638-645
    • Day, J.H.1    Briscoe, M.2    Widlitz, M.D.3
  • 34
    • 1642394844 scopus 로고    scopus 로고
    • Randomized double-blind comparison of cetirizine and fexofenadine after pollen challenge in the Environmental Exposure Unit: Duration of effect in subjects with seasonal allergic rhinitis
    • Day JH, Briscoe MP, Rafeiro E, Hewlett D Jr, Chapman D, Kramer B. Randomized double-blind comparison of cetirizine and fexofenadine after pollen challenge in the Environmental Exposure Unit: duration of effect in subjects with seasonal allergic rhinitis. Allergy Asthma Proc. 2004;25:59-68.
    • (2004) Allergy Asthma Proc , vol.25 , pp. 59-68
    • Day, J.H.1    Briscoe, M.P.2    Rafeiro, E.3    Hewlett Jr., D.4    Chapman, D.5    Kramer, B.6
  • 35
    • 0031449019 scopus 로고    scopus 로고
    • Onset of action, efficacy, and safety of a single dose of fexofenadine hydrochloride for ragweed allergy using an environmental exposure unit
    • Day JH, Briscoe MP, Welsh A, et al. Onset of action, efficacy, and safety of a single dose of fexofenadine hydrochloride for ragweed allergy using an environmental exposure unit. Ann Allergy Asthma Immunol. 1997;79:533-540.
    • (1997) Ann Allergy Asthma Immunol , vol.79 , pp. 533-540
    • Day, J.H.1    Briscoe, M.P.2    Welsh, A.3
  • 36
    • 0031962480 scopus 로고    scopus 로고
    • Cetirizine and hydrocortisone differentially regulate ICAM-1 expression and chemokine release in cultured human keratinocytes
    • Albanesi C, Pasture S, Fanales-Belasio E, Girolomoni G. Cetirizine and hydrocortisone differentially regulate ICAM-1 expression and chemokine release in cultured human keratinocytes. Clin Exp Allergy. 1998;28:101-109.
    • (1998) Clin Exp Allergy , vol.28 , pp. 101-109
    • Albanesi, C.1    Pasture, S.2    Fanales-Belasio, E.3    Girolomoni, G.4
  • 37
    • 0037661233 scopus 로고    scopus 로고
    • Cetirizine modulates adhesion molecule expression in a double-blind controlled study conducted in psoriatic patients [published correction appears in Int J Tissue React. 2003;25:79]
    • Pestelli E, Floriani I, Fabbri P, Caproni M. Cetirizine modulates adhesion molecule expression in a double-blind controlled study conducted in psoriatic patients [published correction appears in Int J Tissue React. 2003;25:79]. Int J Tissue React. 2003;25:1-8.
    • (2003) Int J Tissue React , vol.25 , pp. 1-8
    • Pestelli, E.1    Floriani, I.2    Fabbri, P.3    Caproni, M.4
  • 38
    • 0035319303 scopus 로고    scopus 로고
    • Desloratadine: A new, nonsedating, oral antihistamine
    • Geha RS, Meltzer EO. Desloratadine: a new, nonsedating, oral antihistamine. J Allergy Clin Immunol. 2001;107:751-762.
    • (2001) J Allergy Clin Immunol , vol.107 , pp. 751-762
    • Geha, R.S.1    Meltzer, E.O.2
  • 39
  • 40
    • 0032435662 scopus 로고    scopus 로고
    • Terfenadine and fexofenadine reduce in vitro ICAM-1 expression on human continuous cell lines
    • Paolieri F, Battifora M, Riccio AM, et al. Terfenadine and fexofenadine reduce in vitro ICAM-1 expression on human continuous cell lines. Ann Allergy Asthma Immunol. 1998;81:601-607.
    • (1998) Ann Allergy Asthma Immunol , vol.81 , pp. 601-607
    • Paolieri, F.1    Battifora, M.2    Riccio, A.M.3
  • 41
    • 0033746828 scopus 로고    scopus 로고
    • Sedation and antihistamines: A review of inter-drug differences using proportional impairment ratios
    • Shamsi Z, Hindmarch I. Sedation and antihistamines: a review of inter-drug differences using proportional impairment ratios. Hum Psychopharmacol. 2000;15:S3-S30.
    • (2000) Hum Psychopharmacol , vol.15
    • Shamsi, Z.1    Hindmarch, I.2
  • 42
    • 0032807637 scopus 로고    scopus 로고
    • Antihistamines: Models to assess sedative properties, assessment of sedation, safety and other side-effects
    • Hindmarch I, Shamsi Z. Antihistamines: models to assess sedative properties, assessment of sedation, safety and other side-effects. Clin Exp Allergy. 1999;29(suppl 3):133-142.
    • (1999) Clin Exp Allergy , vol.29 , Issue.SUPPL. 3 , pp. 133-142
    • Hindmarch, I.1    Shamsi, Z.2
  • 43
    • 0030011760 scopus 로고    scopus 로고
    • Cardiac actions of antihistamines
    • Woosley RL. Cardiac actions of antihistamines. Annu Rev Pharmacol Toxicol. 1996;36:233-252.
    • (1996) Annu Rev Pharmacol Toxicol , vol.36 , pp. 233-252
    • Woosley, R.L.1
  • 45
    • 0037477516 scopus 로고    scopus 로고
    • Kenilworth, NJ: Schering Corporation
    • Clarinex [package insert]. Kenilworth, NJ: Schering Corporation; 2002. Available at: www.spfiles.com/piclarinex.pdf. Accessibility verified July 13, 2005.
    • (2002) Clarinex [Package Insert]
  • 46
    • 0032803083 scopus 로고    scopus 로고
    • Cardiovascular safety of fexofenadine HCl
    • Pratt C, Brown AM, Rampe D, et al. Cardiovascular safety of fexofenadine HCl. Clin Exp Allergy. 1999;29(suppl 3):212-216.
    • (1999) Clin Exp Allergy , vol.29 , Issue.SUPPL. 3 , pp. 212-216
    • Pratt, C.1    Brown, A.M.2    Rampe, D.3
  • 48
    • 0028882348 scopus 로고
    • Loratadine administered concomitantly with erythromycin: Pharmacokinetic and electrocardiographic evaluations
    • Brannan MD, Reidenberg P, Radwanski E, et al. Loratadine administered concomitantly with erythromycin: pharmacokinetic and electrocardiographic evaluations. Clin Pharmacol Ther. 1995;58:269-278.
    • (1995) Clin Pharmacol Ther , vol.58 , pp. 269-278
    • Brannan, M.D.1    Reidenberg, P.2    Radwanski, E.3
  • 50
    • 0035138854 scopus 로고    scopus 로고
    • Suppression of the early and late cutaneous allergic responses using fexofenadine and montelukast
    • Simons FE, Johnston L, Gu X, Simons KJ. Suppression of the early and late cutaneous allergic responses using fexofenadine and montelukast. Ann Allergy Asthma Immunol. 2001;86:44-50.
    • (2001) Ann Allergy Asthma Immunol , vol.86 , pp. 44-50
    • Simons, F.E.1    Johnston, L.2    Gu, X.3    Simons, K.J.4
  • 51
    • 0035869636 scopus 로고    scopus 로고
    • Histamine induces exocytosis and IL-6 production from human lung macrophages through interaction with H1 receptors
    • Triggiani M, Gentile M, Seconde A, et al. Histamine induces exocytosis and IL-6 production from human lung macrophages through interaction with H1 receptors. J Immunol. 2001;166:4083-4091.
    • (2001) J Immunol , vol.166 , pp. 4083-4091
    • Triggiani, M.1    Gentile, M.2    Seconde, A.3
  • 52
    • 0009458726 scopus 로고    scopus 로고
    • Evaluation of desloratadine for absorption drug-drug interactions with ketoconazole
    • Hwang K, Correll M, Offord SJ. Evaluation of desloratadine for absorption drug-drug interactions with ketoconazole. J Allergy Clin Immunol. 2001;107(2, pt 2):S153.
    • (2001) J Allergy Clin Immunol , vol.107 , Issue.2 PART 2
    • Hwang, K.1    Correll, M.2    Offord, S.J.3
  • 53
  • 55
    • 0032793959 scopus 로고    scopus 로고
    • OATP and P-glycoprotein transporters mediate the cellular uptake and excretion of fexofenadine
    • Cvetkovic M, Leake B, Fromm MF, Wilkinson GR, Kim RB. OATP and P-glycoprotein transporters mediate the cellular uptake and excretion of fexofenadine. Drug Metab Dispos. 1999;27:866-871.
    • (1999) Drug Metab Dispos , vol.27 , pp. 866-871
    • Cvetkovic, M.1    Leake, B.2    Fromm, M.F.3    Wilkinson, G.R.4    Kim, R.B.5
  • 58
    • 85030743574 scopus 로고    scopus 로고
    • Determining the membrane permeability of newer antihistamines: Implications for central nervous system function and safety
    • Tejani-Butt S, Yaroslavsky I. Determining the membrane permeability of newer antihistamines: implications for central nervous system function and safety [abstract]. Proc 22nd EAACI. 2003:276. Abstract 959.
    • (2003) Proc 22nd EAACI , pp. 276
    • Tejani-Butt, S.1    Yaroslavsky, I.2
  • 59
    • 0142059246 scopus 로고    scopus 로고
    • Fexofenadine hydrochloride, 180 mg, exhibits equivalent efficacy to cetirizine, 10 mg, with less drowsiness in patients with moderate-to-severe seasonal allergic rhinitis
    • Hampel F, Ratner P, Mansfield L, Meeves S, Liao Y, Georges G. Fexofenadine hydrochloride, 180 mg, exhibits equivalent efficacy to cetirizine, 10 mg, with less drowsiness in patients with moderate-to-severe seasonal allergic rhinitis. Ann Allergy Asthma Immunol. 2003;91:354-361.
    • (2003) Ann Allergy Asthma Immunol , vol.91 , pp. 354-361
    • Hampel, F.1    Ratner, P.2    Mansfield, L.3    Meeves, S.4    Liao, Y.5    Georges, G.6
  • 60
    • 0032803157 scopus 로고    scopus 로고
    • Assessment of antihistamine efficacy and potency
    • Howarth PH. Assessment of antihistamine efficacy and potency. Clin Exp Allergy. 1999;29(suppl 3):87-97.
    • (1999) Clin Exp Allergy , vol.29 , Issue.SUPPL. 3 , pp. 87-97
    • Howarth, P.H.1
  • 62
    • 8644255952 scopus 로고    scopus 로고
    • Advances in H1-antihistamines
    • Simons FE. Advances in H1-antihistamines. N Engl J Med. 2004;351: 2203-2217.
    • (2004) N Engl J Med , vol.351 , pp. 2203-2217
    • Simons, F.E.1
  • 63
    • 0032799404 scopus 로고    scopus 로고
    • A double-blind, placebo-controlled investigation of the effects of fexofenadine, loratadine and promethazine on cognitive and psychomotor function
    • Hindmarch I, Shamsi Z, Stanley N, Fairweather DB. A double-blind, placebo-controlled investigation of the effects of fexofenadine, loratadine and promethazine on cognitive and psychomotor function. Br J Clin Pharmacol. 1999;48:200-206.
    • (1999) Br J Clin Pharmacol , vol.48 , pp. 200-206
    • Hindmarch, I.1    Shamsi, Z.2    Stanley, N.3    Fairweather, D.B.4
  • 64
    • 0036118760 scopus 로고    scopus 로고
    • An evaluation of the effects of high-dose fexofenadine on the central nervous system: A double-blind, placebo-controlled study in healthy volunteers
    • Hindmarch I, Shamsi Z, Kimber S. An evaluation of the effects of high-dose fexofenadine on the central nervous system: a double-blind, placebo-controlled study in healthy volunteers. Clin Exp Allergy. 2002;32:133-139.
    • (2002) Clin Exp Allergy , vol.32 , pp. 133-139
    • Hindmarch, I.1    Shamsi, Z.2    Kimber, S.3
  • 65
    • 0034728807 scopus 로고    scopus 로고
    • Sedation with "non-sedating" antihistamines: Four prescription-event monitoring studies in general practice
    • Mann RD, Pearce GL, Dunn N, Shakir S. Sedation with "non- sedating" antihistamines: four prescription-event monitoring studies in general practice. BMJ 2000;320:1184-1186.
    • (2000) BMJ , vol.320 , pp. 1184-1186
    • Mann, R.D.1    Pearce, G.L.2    Dunn, N.3    Shakir, S.4
  • 67
    • 3242751214 scopus 로고    scopus 로고
    • Central effects of fexofenadine and cetirizine: Measurement of psychomotor performance, subjective sleepiness, and brain histamine H1-receptor occupancy using 11C-doxepin positron emission tomography
    • Tashiro M, Sakurada Y, Iwabuchi K, et al. Central effects of fexofenadine and cetirizine: measurement of psychomotor performance, subjective sleepiness, and brain histamine H1-receptor occupancy using 11C-doxepin positron emission tomography. J Clin Pharmacol. 2004;44:890-900.
    • (2004) J Clin Pharmacol , vol.44 , pp. 890-900
    • Tashiro, M.1    Sakurada, Y.2    Iwabuchi, K.3
  • 68
    • 0034090862 scopus 로고    scopus 로고
    • Effects of fexofenadine, diphenhydramine, and alcohol on driving performance: A randomized, placebo-controlled trial in the Iowa driving simulator
    • Weiler JM, Bloomfield JR, Woodworth GG, et al. Effects of fexofenadine, diphenhydramine, and alcohol on driving performance: a randomized, placebo-controlled trial in the Iowa driving simulator. Ann Intern Med. 2000;132:354-363.
    • (2000) Ann Intern Med , vol.132 , pp. 354-363
    • Weiler, J.M.1    Bloomfield, J.R.2    Woodworth, G.G.3
  • 69
    • 4043089083 scopus 로고    scopus 로고
    • Effects of desloratadine, diphenhydramine, and placebo on driving performance and psychomotor performance measurements
    • Vuurman EF, Rikken GH, Muntjewerff ND, de Haileux F, Ramaekers JG. Effects of desloratadine, diphenhydramine, and placebo on driving performance and psychomotor performance measurements. Eur J Clin Pharmacol. 2004;60:307-313.
    • (2004) Eur J Clin Pharmacol , vol.60 , pp. 307-313
    • Vuurman, E.F.1    Rikken, G.H.2    Muntjewerff, N.D.3    De Haileux, F.4    Ramaekers, J.G.5
  • 70
    • 0042877021 scopus 로고    scopus 로고
    • Driving ability after acute and sub-chronic administration of levocetirizine and diphenhydramine: A randomized, double-blind, placebo-controlled trial
    • Verster JC, de Weert AM, Bijtjes SI, et al. Driving ability after acute and sub-chronic administration of levocetirizine and diphenhydramine: a randomized, double-blind, placebo-controlled trial. Psychopharmacology (Berl). 2003;169:84-90.
    • (2003) Psychopharmacology (Berl) , vol.169 , pp. 84-90
    • Verster, J.C.1    De Weert, A.M.2    Bijtjes, S.I.3
  • 71
    • 0026540567 scopus 로고
    • Effects of loratadine and cetirizine on actual driving and psychometric test performance, and EEG during driving
    • Ramaekers JG, Uiterwijk MM, O'Hanlon JF. Effects of loratadine and cetirizine on actual driving and psychometric test performance, and EEG during driving. Eur J Clin Pharmacol. 1992;42:363-369.
    • (1992) Eur J Clin Pharmacol , vol.42 , pp. 363-369
    • Ramaekers, J.G.1    Uiterwijk, M.M.2    O'Hanlon, J.F.3
  • 72
    • 0034142033 scopus 로고    scopus 로고
    • Cardiotoxic potential and CNS effects of first-generation antihistamines
    • Taglialatela M, Timmerman H, Annunziato L. Cardiotoxic potential and CNS effects of first-generation antihistamines. Trends Pharmacol Sci. 2000; 21:52-56.
    • (2000) Trends Pharmacol Sci , vol.21 , pp. 52-56
    • Taglialatela, M.1    Timmerman, H.2    Annunziato, L.3
  • 74
    • 0036279872 scopus 로고    scopus 로고
    • Effect of desloratadine versus placebo on nasal airflow and subjective measures of nasal obstruction in subjects with grass pollen-induced allergic rhinitis in an allergen-exposure unit
    • Horak F, Stubner UP, Zieglmayer R, Harris AG. Effect of desloratadine versus placebo on nasal airflow and subjective measures of nasal obstruction in subjects with grass pollen-induced allergic rhinitis in an allergen-exposure unit. J Allergy Clin Immunol. 2002;109:956-961.
    • (2002) J Allergy Clin Immunol , vol.109 , pp. 956-961
    • Horak, F.1    Stubner, U.P.2    Zieglmayer, R.3    Harris, A.G.4
  • 75
    • 0034067927 scopus 로고    scopus 로고
    • Double-blind study of cetirizine and loratadine versus placebo in patients with allergic rhinitis
    • Nunes C, Ladeira S. Double-blind study of cetirizine and loratadine versus placebo in patients with allergic rhinitis. J Investig Allergol Clin Immunol. 2000;10:20-23.
    • (2000) J Investig Allergol Clin Immunol , vol.10 , pp. 20-23
    • Nunes, C.1    Ladeira, S.2
  • 76
    • 0036408830 scopus 로고    scopus 로고
    • Effects of fexofenadine and desloratadine on subjective and objective measures of nasal congestion in seasonal allergic rhinitis
    • Wilson AM, Haggart K, Sims EJ, Lipworth BJ. Effects of fexofenadine and desloratadine on subjective and objective measures of nasal congestion in seasonal allergic rhinitis. Clin Exp Allergy. 2002;32:1504-1509.
    • (2002) Clin Exp Allergy , vol.32 , pp. 1504-1509
    • Wilson, A.M.1    Haggart, K.2    Sims, E.J.3    Lipworth, B.J.4
  • 77
    • 0032845559 scopus 로고    scopus 로고
    • Validation of the standardized version of the Rhinoconjunctivitis Quality of Life Questionnaire
    • Juniper EF, Thompson AK, Ferrie PJ, Roberts JN. Validation of the standardized version of the Rhinoconjunctivitis Quality of Life Questionnaire. J Allergy Clin Immunol. 1999;104(2, pt 1):364-369.
    • (1999) J Allergy Clin Immunol , vol.104 , Issue.2 PART 1 , pp. 364-369
    • Juniper, E.F.1    Thompson, A.K.2    Ferrie, P.J.3    Roberts, J.N.4
  • 78
    • 0029791103 scopus 로고    scopus 로고
    • Improvement of quality of life by treatment with cetirizine in patients with perennial allergic rhinitis as determined by a French version of the SF-36 questionnaire
    • Bousquet J, Duchateau J, Pignat JC, et al. Improvement of quality of life by treatment with cetirizine in patients with perennial allergic rhinitis as determined by a French version of the SF-36 questionnaire. J Allergy Clin Immunol. 1996;98:309-316.
    • (1996) J Allergy Clin Immunol , vol.98 , pp. 309-316
    • Bousquet, J.1    Duchateau, J.2    Pignat, J.C.3
  • 79
    • 0032946674 scopus 로고    scopus 로고
    • Effect of fexofenadine HCl on quality of life and work, classroom, and daily activity impairment in patients with seasonal allergic rhinitis
    • Tanner LA, Reilly M, Meltzer EO, Bradford JE, Mason J. Effect of fexofenadine HCl on quality of life and work, classroom, and daily activity impairment in patients with seasonal allergic rhinitis. Am J Manag Care. 1999; 5:S235-S247.
    • (1999) Am J Manag Care , vol.5
    • Tanner, L.A.1    Reilly, M.2    Meltzer, E.O.3    Bradford, J.E.4    Mason, J.5
  • 80
    • 15844380989 scopus 로고    scopus 로고
    • Fexofenadine improves the quality of life and work productivity in Japanese patients with seasonal allergic rhinitis during the peak cedar pollinosis season
    • Okubo K, Gotoh M, Shimada K, Ritsu M, Okuda M, Crawford B. Fexofenadine improves the quality of life and work productivity in Japanese patients with seasonal allergic rhinitis during the peak cedar pollinosis season. Int Arch Allergy Immunol. 2005;136:148-154.
    • (2005) Int Arch Allergy Immunol , vol.136 , pp. 148-154
    • Okubo, K.1    Gotoh, M.2    Shimada, K.3    Ritsu, M.4    Okuda, M.5    Crawford, B.6
  • 81
    • 0032697271 scopus 로고    scopus 로고
    • Once-daily fexofenadine HCl improves quality of life and reduces work and activity impairment in patients with seasonal allergic rhinitis
    • Meltzer EO, Casale TB, Nathan RA, Thompson AK. Once-daily fexofenadine HCl improves quality of life and reduces work and activity impairment in patients with seasonal allergic rhinitis. Ann Allergy Asthma Immunol. 1999;83:311-317.
    • (1999) Ann Allergy Asthma Immunol , vol.83 , pp. 311-317
    • Meltzer, E.O.1    Casale, T.B.2    Nathan, R.A.3    Thompson, A.K.4
  • 82
    • 0037337119 scopus 로고    scopus 로고
    • The health-related quality of life effects of once-daily cetirizine HCl in patients with seasonal allergic rhinitis: A randomized double-blind, placebo-controlled trial
    • Noonan MJ, Raphael GD, Nayak A, et al. The health-related quality of life effects of once-daily cetirizine HCl in patients with seasonal allergic rhinitis: a randomized double-blind, placebo-controlled trial. Clin Exp Allergy. 2003;33:351-358.
    • (2003) Clin Exp Allergy , vol.33 , pp. 351-358
    • Noonan, M.J.1    Raphael, G.D.2    Nayak, A.3
  • 83
    • 0036878197 scopus 로고    scopus 로고
    • Comprehensive evaluation of cetirizine in the management of seasonal allergic rhinitis: Impact on symptoms, quality of life, productivity, and activity impairment
    • Murray JJ, Nathan RA, Bronsky EA, Olufade AO, Chapman D, Kramer B. Comprehensive evaluation of cetirizine in the management of seasonal allergic rhinitis: impact on symptoms, quality of life, productivity, and activity impairment. Allergy Asthma Proc. 2002;23:391-398.
    • (2002) Allergy Asthma Proc , vol.23 , pp. 391-398
    • Murray, J.J.1    Nathan, R.A.2    Bronsky, E.A.3    Olufade, A.O.4    Chapman, D.5    Kramer, B.6
  • 84
    • 0034082414 scopus 로고    scopus 로고
    • Triamcinolone acetonide aqueous nasal spray versus loratadine in seasonal allergic rhinitis: Efficacy and quality of life
    • Condemi J, Schulz R, Lim J. Triamcinolone acetonide aqueous nasal spray versus loratadine in seasonal allergic rhinitis: efficacy and quality of life. Ann Allergy Asthma Immunol. 2000;84:533-538.
    • (2000) Ann Allergy Asthma Immunol , vol.84 , pp. 533-538
    • Condemi, J.1    Schulz, R.2    Lim, J.3
  • 85
    • 4944246449 scopus 로고    scopus 로고
    • Levocetirizine improves quality of life and reduces costs in long-term management of persistent allergic rhinitis
    • Bachert C, Bousquet J, Canonica GW, et al, XPERT Study Group. Levocetirizine improves quality of life and reduces costs in long-term management of persistent allergic rhinitis. J Allergy Clin Immunol. 2004;114: 838-844.
    • (2004) J Allergy Clin Immunol , vol.114 , pp. 838-844
    • Bachert, C.1    Bousquet, J.2    Canonica, G.W.3
  • 86
    • 0141465572 scopus 로고    scopus 로고
    • Health-related quality of life outcomes of desloratadine in patients with moderate-to-severe SAR
    • Schmier J, Leidy N, Prasad M. Health-related quality of life outcomes of desloratadine in patients with moderate-to-severe SAR [abstract]. Ann Allergy Asthma Immunol. 2001;86:111. Abstract P69.
    • (2001) Ann Allergy Asthma Immunol , vol.86 , pp. 111
    • Schmier, J.1    Leidy, N.2    Prasad, M.3
  • 87
    • 0001518177 scopus 로고    scopus 로고
    • Quality of life in patients with seasonal allergic rhinitis is improved by desloratadine
    • Coren J, Salmun M. Quality of life in patients with seasonal allergic rhinitis is improved by desloratadine. Allergy. 2000;55(suppl 63):191.
    • (2000) Allergy , vol.55 , Issue.SUPPL. 63 , pp. 191
    • Coren, J.1    Salmun, M.2
  • 88
    • 85030748428 scopus 로고    scopus 로고
    • First Word, April 21
    • Hoffmann C. Seasonal allergy treatment affected by OTC Claritin. First Word, April 21, 2003. Available at: www.firstwordplus.com/Fws.do?articleid= 0053C577AEE5A70285256D0F00740323. Accessibility verified July 13, 2005.
    • (2003) Seasonal Allergy Treatment Affected by OTC Claritin
    • Hoffmann, C.1


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.